Altria
MO
$68.98
+0.28%
Altria Group, Inc. is a leading U.S. tobacco company that manufactures and sells cigarettes, smokeless tobacco products, machine-made cigars, and innovative nicotine products, operating primarily in the consumer defensive sector. With iconic brands like Marlboro, which holds a 40% U.S. cigarette market share, Altria is the dominant player in the domestic tobacco industry, also holding strategic stakes in Anheuser-Busch InBev and Cronos Group. The current investor narrative centers on Altria's transition toward reduced-risk products (e.g., NJOY vaping, On! nicotine pouches) amid declining cigarette volumes, with recent Q2 earnings missing expectations and a raised guidance midpoint that still lagged analyst forecasts, fueling debate about the sustainability of its high dividend and long-term growth prospects.…
MO
Altria
$68.98
Related headlines
MO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Altria's 12-month outlook, with a consensus price target around $70.00 and implied upside of +1.5% versus the current price.
Average Target
$70.00
0 analysts
Implied Upside
+1.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$58 - $82
Analyst target range
The target price range spans from $58.00 (low) to $82.00 (high), representing a wide 41% spread that underscores significant uncertainty about Altria's future. The low target of $58.00 implies a 15.8% downside, likely pricing in continued volume declines and regulatory risks, while the high target of $82.00 suggests a 19.0% upside, assuming successful smoke-free product adoption and stable cash flows. Recent institutional actions show no major upgrades or downgrades, with most firms maintaining their ratings, indicating a stable but watchful stance. The wide range and hold consensus suggest that analysts are waiting for clearer evidence of Altria's transformation success before becoming more bullish.
Bulls vs Bears: MO Investment Factors
Altria presents a mixed investment case with strong profitability and valuation appeal offset by structural volume declines and regulatory overhangs. The bull case is anchored by a 20.1% revenue growth, exceptional 72.2% gross margins, and a low forward PE of 11.7x, while the bear case highlights declining cigarette volumes, negative PEG ratio, and high debt levels. Currently, the bearish evidence appears stronger due to the accelerating volume decline and market underperformance, which overshadow the attractive dividend yield. The central tension lies in whether Altria's smoke-free product transition (NJOY, On!) can offset cigarette volume losses—if successful, the stock could re-rate higher; if not, the high dividend may become unsustainable.
Bullish
- Strong Revenue Growth: Q1 2026 revenue grew 20.1% YoY to $5.43B, driven by pricing power and smoke-free product expansion. This robust growth outpaces the broader market and supports continued earnings generation.
- High Profitability Margins: Gross margin stands at 72.2% and operating margin at 59.8%, reflecting Altria's dominant pricing power in the tobacco industry. These exceptional margins provide a strong buffer against volume declines.
- Attractive Valuation: With a trailing PE of 14.0x and forward PE of 11.7x, Altria trades at a significant discount to the broader market. The forward PE implies expected earnings growth of ~19%, offering value relative to its defensive nature.
- High Dividend Yield: Altria offers a dividend yield of 7.2%, supported by a payout ratio of 100.2%. This makes it one of the highest-yielding large-cap stocks, appealing to income-focused investors.
Bearish
- Declining Cigarette Volumes: Industry-wide cigarette volumes continue to shrink, and Altria's Q2 2026 earnings missed expectations due to accelerating volume declines. This structural decline threatens long-term revenue sustainability.
- Underperformance vs Market: Altria's 1-year return of +3.4% significantly lags the S&P 500's +18.7%, with negative relative strength of -15.2%. This underperformance reflects investor skepticism about its growth prospects.
- Negative PEG Ratio: The PEG ratio of -0.38 indicates negative earnings growth expectations, which is unusual and signals potential earnings contraction ahead. This could lead to further multiple compression.
- High Debt Levels: With a debt-to-equity ratio of -7.34 and current ratio of 0.61, Altria carries substantial debt and has weak liquidity. This financial leverage increases vulnerability to interest rate hikes and economic downturns.
MO Technical Analysis
Altria's stock is in a broad recovery phase, having gained 3.4% over the past year, though it remains well below its 52-week high of $77.06. Currently trading at $68.88, the stock sits at approximately 89% of its 52-week range (from low of $54.70 to high of $77.06), indicating a position closer to the upper end but with room to challenge prior peaks. The 1-year price change of +3.4% contrasts sharply with the S&P 500's +18.7% gain, reflecting significant underperformance and a defensive posture that has lagged the broader market rally.
Beta
0.49
0.49x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$55-$77
Price range past year
Annual Return
+3.9%
Cumulative gain past year
| Period | MO Return | S&P 500 |
|---|---|---|
| 1m | +7.1% | -1.1% |
| 3m | -4.1% | +3.0% |
| 6m | +1.6% | +15.4% |
| 1y | +3.9% | +16.2% |
| ytd | +20.4% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MO Fundamental Analysis
Altria's revenue trajectory shows robust growth, with Q1 2026 revenue of $5.43 billion, up 20.1% year-over-year, driven by strong performance in smokeable products ($4.76 billion) and smokeless products ($669 million). However, this growth is partly due to pricing power offsetting volume declines, as cigarette volumes continue to shrink industry-wide. The multi-quarter trend reveals revenue acceleration from $4.52 billion in Q1 2025 to $5.43 billion in Q1 2026, but Q4 2025 revenue of $5.85 billion suggests sequential moderation, indicating that growth may be peaking.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+20.1%
YoY Comparison
Gross Margin
64.6%
Latest Quarter
Free Cash Flow
$8.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MO Overvalued?
Given Altria's positive net income, the PE ratio is the primary valuation metric. The trailing PE stands at 14.0x, while the forward PE is 11.7x, implying the market expects earnings growth of approximately 19% over the next year. This gap suggests optimism about future profitability, likely driven by cost efficiencies and reduced-risk product expansion. The PEG ratio of -0.38 is negative due to negative earnings growth expectations, which is unusual and warrants caution.
PE
14.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.9x
Enterprise Value Multiple